SCHEMBL24906290

SCHEMBL24906290

CCOC(=O)c1[nH]nc(C(F)(F)F)c1I

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.48
MAPT P10636 2/20 0.48
POLB P06746 1/20 0.48
KMT2A Q03164 1/20 0.48
HSD17B10 Q99714 2/20 0.42
PDE4D Q08499 1/20 0.41
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
NPSR1 Q6W5P4 1/20 0.38
HPGD P15428 4/20 0.38
ALDH1A1 P00352 3/20 0.38
HTT P42858 1/20 0.38
RECQL P46063 1/20 0.38
IDO1 P14902 1/20 0.36
AURKA O14965 1/20 0.36
MAPK10 P53779 1/20 0.36
RIPK1 Q13546 1/20 0.36
CDC25B P30305 1/20 0.36
DUSP3 P51452 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24906255 0.90 KDM4E (0.47) KDM4EMAPTPOLBKMT2AHSD17B10
SCHEMBL30976019 0.86 KDM4E (0.43) KDM4EMAPTPOLBKMT2AHSD17B10
SCHEMBL30975896 0.85 KDM4E (0.42) KDM4EMAPTPOLBKMT2AHSD17B10
SCHEMBL13365026 0.84 KDM4E (0.50) KDM4EMAPTPOLBKMT2AHSD17B10
SCHEMBL2363099 0.83 KDM4E (0.49) KDM4EMAPTPOLBKMT2AHSD17B10
SCHEMBL13682657 0.83 KDM4E (0.49) KDM4EMAPTPOLBKMT2AHSD17B10
SCHEMBL14487734 0.82 KDM4E (0.48) KDM4EMAPTPOLBKMT2AHSD17B10
SCHEMBL13163303 0.82 KDM4E (0.48) KDM4EMAPTPOLBKMT2AHSD17B10
SCHEMBL10717172 0.82 KDM4E (0.48) KDM4EMAPTPOLBKMT2AHSD17B10
SCHEMBL28724964 0.78 KDM4E (0.45) KDM4EMAPTPOLBKMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11999699-B2 Substituted pyrazole amides Grünenthal GmbH (DE) 2024-06-04 US disclosed
EP-4355733-A1 SUBSTITUTED PYRAZOLE AMIDES Grünenthal GmbH (DE) 2024-04-24 EP disclosed
US-20230025025-A1 SUBSTITUTED PYRAZOLE AMIDES GRUENENTHAL GMBH (DE) 2023-01-26 US disclosed
US-20230025025-A1 SUBSTITUTED PYRAZOLE AMIDES GRUENENTHAL GMBH (DE) 2023-01-26 US disclosed
WO-2022263498-A1 SUBSTITUTED PYRAZOLE AMIDES Grünenthal GmbH (DE) 2022-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11999699-B2 Substituted pyrazole amides SCN8A, SCN1A, SCN7A KDM4E 2803/4885MAPT 2901/4885POLB 4395/4885
US-20230025025-A1 SUBSTITUTED PYRAZOLE AMIDES SCN8A, SCN1A, SCN7A KDM4E 2803/4885MAPT 2901/4885POLB 4395/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.